Be sure to catch up on the latest happenings in our spring newsletter here! Nancy Farrugia Related posts2023 Fall NewsletterOctober 12, 20232023 Summer NewsletterJuly 13, 2023Intellia Therapeutics Receives Authorization to Initiate Phase 1 Clinical Trial of NTLA-2001 for Transthyretin Amyloidosis (ATTR)October 19, 2020 Previous post2026 Winter Newsletter
